Difficulty: Medium
Average Score: 75%
Practice
Which of the following chemotherapy agents are correctly paired according to their mechanism of action?
Correct answer
C
Rationale
In this question, the correct pairing is option C) Docetaxel and paclitaxel. Both of these drugs belong to the class of taxanes and act by stabilizing microtubules, thereby inhibiting mitosis in rapidly dividing cells. This mechanism of action makes them effective in treating various cancers, including breast, lung, and ovarian cancers.
Option A) Vincristine and paclitaxel is incorrect because Vincristine is a vinca alkaloid that acts by disrupting microtubule formation, leading to cell cycle arrest in metaphase.
Option B) Etoposide and paclitaxel is also incorrect as Etoposide is a topoisomerase inhibitor, which works by interfering with the enzyme topoisomerase II and causing DNA damage.
Option D) Docetaxel and etoposide is incorrect because, as mentioned earlier, Docetaxel acts as a taxane by stabilizing microtubules, whereas etoposide is a topoisomerase inhibitor.
Understanding the mechanism of action of chemotherapy drugs is crucial for healthcare professionals involved in cancer treatment. Knowing which drugs act on specific targets in the cell cycle helps in selecting the most appropriate treatment regimens and managing potential side effects. This knowledge is essential for optimizing patient care and outcomes in oncology practice.
Option A) Vincristine and paclitaxel is incorrect because Vincristine is a vinca alkaloid that acts by disrupting microtubule formation, leading to cell cycle arrest in metaphase.
Option B) Etoposide and paclitaxel is also incorrect as Etoposide is a topoisomerase inhibitor, which works by interfering with the enzyme topoisomerase II and causing DNA damage.
Option D) Docetaxel and etoposide is incorrect because, as mentioned earlier, Docetaxel acts as a taxane by stabilizing microtubules, whereas etoposide is a topoisomerase inhibitor.
Understanding the mechanism of action of chemotherapy drugs is crucial for healthcare professionals involved in cancer treatment. Knowing which drugs act on specific targets in the cell cycle helps in selecting the most appropriate treatment regimens and managing potential side effects. This knowledge is essential for optimizing patient care and outcomes in oncology practice.